Preceptis Medical, Inc. — SEC Form D Filing

Preceptis Medical, Inc. filed an SEC Form D on May 1, 2026, reporting $2.56M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
May 1, 2026
Amount reported
$2.56M
Round stage
Seed
Industry
Health Care
Website
https://www.hummingbirdeartubes.com/company/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Pediatric ear tube placement is the most common pediatric procedure and exposes children under 3 to the risks of general anesthesia and associated parental stress.

Solution

Preceptis Medical developed the FDA-cleared Hummingbird® Tympanostomy Tube System (TTS), a minimally invasive, office-based device that places ear tubes without general anesthesia, reducing costs and allowing quick recovery.

Verdict

Investors said yes primarily because the Hummingbird system presents a significant advancement in a routine pediatric procedure, minimizing anesthesia risks and streamlining operations for ENT specialists. They were implicitly betting on a growing willingness among parents and doctors to embrace less invasive solutions, not because there was a well-defined market or a strong competitive edge. However, the limited upside lies in the niche nature of pediatric ENT interventions, which could limit scalability compared to broader health care solutions.

Source: SEC EDGAR Form D filing